Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Desloratadine 5 mg tablet vs Aerius in healthy Thai volunteers (fasting, crossover)
TCTR20200814008Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) (2 arms), sponsored by Bio-innova. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20200814008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200814008.